![](https://scx1.b-cdn.net/csz/news/tmb/2021/breast-cancer-3.jpg)
Aromatase inhibitors better than tamoxifen at reducing the risk of breast cancer recurrence in women
A new study has shown that giving aromatase inhibitors instead of tamoxifen to premenopausal women with estrogen receptor positive (hormone-sensitive) breast cancer significantly reduces the risk of breast cancer recurrence. ...
Feb 3, 2022
0
67